Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults
Clinical trial NCT07675629 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07675629
- Sponsor
- Worcester HIV Vaccine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-08-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.